Jenburkt Pharmaceuticals standalone net profit declines 24.39% in the June 2026 quarter

Sales decline 0.06% to Rs 35.51 crore

Net profit of Jenburkt Pharmaceuticals declined 24.39% to Rs 5.89 crore in the quarter ended June 2026 as against Rs 7.79 crore during the previous quarter ended June 2025. Sales declined 0.06% to Rs 35.51 crore in the quarter ended June 2026 as against Rs 35.53 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	35.51	35.53	0
OPM %	16.98	25.19	-
PBDT	7.41	10.90	-32
PBT	6.77	10.18	-33
NP	5.89	7.79	-24

Powered by Capital Market - Live News